Kaplan & Sadock's Pocket Handbook of Psychiatric Drug Treatment
This book is currently unavailable – please contact us for further information.
€60.16
(To see other currencies, click on price)
(To see other currencies, click on price)
Paperback / softback
Overview
Products Details
Customer Reviews
MORE ABOUT THIS BOOK
Main description:
Kaplan & Sadock's Pocket Handbook of Psychiatric Drug Treatment covers the entire spectrum of clinical drug therapy for adults, elderly adults, pregnant and nursing women, and children. Drugs are listed alphabetically, for quick navigation, and each drug entry includes name, molecular structure, dosing, pharmacological actions, indications and clinical applications, side effects and adverse/allergic reactions, and drug interactions. In the front are tables listing the chapters where each drug is discussed and the common disorders for which each is used. Color drug plates in the front help with rapid recognition of all major drugs.
Contents:
Contents
Preface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . vii
Acknowledgments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ix
1. General Principles of Psychopharmacology . . . . . . . . . . . . . . . . . . . . . . . . . 1
2. α2-Adrenergic Receptor Agonists, α1-Adrenergic Receptor Antagonists:
Clonidine, Guanfacine, Minipress and Yohimbine. . . . . . . . . . . . . . . . . . . . 25
3. β-Adrenergic Receptor Antagonists . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
4. Anticholinergics and Amantadine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
5. Anticonvulsants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
6. Antihistamines . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
7. Barbiturates and Similarly Acting Drugs . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
8. Benzodiazepines and Drugs Acting on Benzodiazepine Receptors . . . . . 68
9. Bupropion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
10. Buspirone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
11. Calcium Channel Inhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
12. Carbamazepine and Oxcarbazepine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93
13. Cholinesterase Inhibitors and Memantine . . . . . . . . . . . . . . . . . . . . . . . . . . . 101
14. Disulfiram and Acamprosate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108
15. Dopamine Receptor Agonists and Precursors . . . . . . . . . . . . . . . . . . . . . . . . 113
16. Dopamine Receptor Antagonists (First Generation Antipsychotics) . . . . 118
17. Lamotrigine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 137
18. Lithium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141
19. Melatonin Agonists: Ramelton and Melatonin . . . . . . . . . . . . . . . . . . . . . . . 157
20. Mirtazapine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 161
21. Monoamine Oxidase Inhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164
22. Nefazodone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 171
23. Opioid Receptor Agonists: Methadone and Buprenorphine . . . . . . . . . . . 174
24. Opioid Receptor Antagonists: Naltrexone, Nalmefene, and Naloxone . . 181
25. Phosphodiesterase-5 Inhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 188
26. Selective Serotonin–Norepinephrine Reuptake Inhibitors . . . . . . . . . . . . . 193
27. Selective Serotonin Reuptake Inhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . . . 200
28. Serotonin–Dopamine Antagonists and Similarly Acting Drugs
(Second Generation or Atypical Antipsychotics) . . . . . . . . . . . . . . . . . . . . . 217
29. Sympathomimetics and Related Drugs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 238
30. Thyroid Hormones . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 248
31. Trazodone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 251
32. Tricyclics and Tetracyclics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 255
33. Valproate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 266
34. Nutritional Supplements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 274
35. Intoxication and Overdose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 288
Index. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 299
About the Authors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 315
PRODUCT DETAILS
ISBN-13: 9781609139681
Publisher: Lippincott Williams & Wilkins
Publication date: August, 2011
Pages: 320
Weight: 1g
Availability: Not available (reason unspecified)
Subcategories: Pharmacology, Psychiatry
Publisher: Lippincott Williams & Wilkins
Publication date: August, 2011
Pages: 320
Weight: 1g
Availability: Not available (reason unspecified)
Subcategories: Pharmacology, Psychiatry
Related books
Publisher recommends
Publisher recommends
CUSTOMER REVIEWS
Average Rating